Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.32 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.31 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9793502 | 0.78 | PTPN2 (0.33) | PTPN2PTPN1 | |
| SCHEMBL7734384 | 0.78 | SHBG (0.36) | ALDH1A1LMNA | |
| SCHEMBL30900217 | 0.77 | — | — | |
| SCHEMBL12446358 | 0.75 | — | — | |
| SCHEMBL14681561 | 0.75 | — | — | |
| SCHEMBL24685640 | 0.74 | — | — | |
| SCHEMBL13172489 | 0.74 | — | — | |
| SCHEMBL2343714 | 0.74 | — | — | |
| SCHEMBL12685881 | 0.73 | ALDH1A1 (0.31) | ALDH1A1LMNATHRBALOX15MAPK1 | |
| SCHEMBL18807606 | 0.73 | POLB (0.32) | ALDH1A1LMNATHRBALOX15MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025003023-A1 | METHOD FOR PRODUCING A CARBOXYLIC ACID | EVONIK OPERATIONS GMBH (DE) | 2025-01-02 | — | — | WO | disclosed |
| WO-2014121037-A1 | HYDROXYLAMINE-TERMINATED POLYSILOXANE AND METHODS OF MAKING AND USING THE SAME | DOW CORNING CORPORATION (US) | 2014-08-07 | — | — | WO | disclosed |
| EP-1544190-B1 | METHOD FOR PRODUCING CARBOXYLIC ACIDS | NAT INST OF ADVANCED IND SCIEN (JP) | 2011-08-31 | — | — | EP | disclosed |
| US-20070128143-A1 | Polyether-modified polysiloxanes with block character and use thereof for producing cosmetic formulations | GOLDSCHMIDT GMBH (DE) | 2007-06-07 | — | — | US | disclosed |
| US-20070128143-A1 | Polyether-modified polysiloxanes with block character and use thereof for producing cosmetic formulations | GOLDSCHMIDT GMBH (DE) | 2007-06-07 | — | — | US | disclosed |
| EP-1792609-A1 | Organomodified block-type polysiloxanes, method for production and use | Goldschmidt GmbH (DE) | 2007-06-06 | — | — | EP | disclosed |
| US-7186858-B2 | Method for producing carboxylic acid | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2007-03-06 | — | — | US | disclosed |
| US-20050215817-A1 | Method for producing carboxylic acid | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2005-09-29 | — | — | US | disclosed |
| EP-1544190-A1 | METHOD FOR PRODUCING CARBOXYLIC ACID | National Institute of Advanced Industrial Science and Technology (JP) | 2005-06-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050215817-A1 | Method for producing carboxylic acid | ADH1C, HAO2, ALDH2 | ALDH1A1 50/4885LMNA 3596/4885THRB 3403/4885 |
| US-20070128143-A1 | Polyether-modified polysiloxanes with block character and use thereof for producing cosmetic formulations | ACMSD, PLOD2, OPRM1 | ALDH1A1 1075/4885LMNA 2607/4885THRB 689/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.